athenahealth, Inc (NASDAQ:ATHN) had its target price raised by Dougherty & Co from $123.00 to $148.00 in a report released on Tuesday. The firm currently has a “buy” rating on the health services provider’s stock. Dougherty & Co’s target price would indicate a potential upside of 10.37% from the company’s previous close.

Several other research firms have also recently weighed in on ATHN. Oppenheimer Holdings Inc. reiterated an “outperform” rating and issued a $154.00 price objective (up previously from $119.00) on shares of athenahealth in a report on Monday, May 22nd. Robert W. Baird set a $140.00 price objective on athenahealth and gave the stock a “buy” rating in a report on Thursday, May 18th. Jefferies Group LLC upgraded athenahealth from an “underperform” rating to a “hold” rating and increased their price objective for the stock from $95.00 to $135.00 in a report on Friday, May 19th. Evercore ISI reiterated an “outperform” rating and issued a $147.00 price objective (up previously from $118.00) on shares of athenahealth in a report on Friday, May 19th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and issued a $140.00 price objective (up previously from $118.00) on shares of athenahealth in a report on Friday, May 19th. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and twelve have assigned a buy rating to the stock. The company presently has an average rating of “Buy” and an average price target of $135.05.

Analyst Recommendations for athenahealth (NASDAQ:ATHN)

athenahealth (NASDAQ:ATHN) traded up 0.56% during mid-day trading on Tuesday, hitting $134.09. The company’s stock had a trading volume of 366,997 shares. The firm’s 50-day moving average is $114.85 and its 200-day moving average is $112.11. The company has a market cap of $5.34 billion, a P/E ratio of 263.96 and a beta of 1.77. athenahealth has a 12-month low of $90.11 and a 12-month high of $142.40.

athenahealth (NASDAQ:ATHN) last released its quarterly earnings data on Thursday, April 27th. The health services provider reported $0.10 earnings per share for the quarter, missing the consensus estimate of $0.11 by $0.01. athenahealth had a return on equity of 6.41% and a net margin of 1.94%. The business had revenue of $285.40 million during the quarter, compared to analysts’ expectations of $296.49 million. During the same quarter last year, the business posted $0.34 EPS. The company’s quarterly revenue was up 11.4% compared to the same quarter last year. Analysts predict that athenahealth will post $1.89 EPS for the current fiscal year.

ILLEGAL ACTIVITY WARNING: This piece was originally posted by American Banking News and is the property of of American Banking News. If you are viewing this piece on another domain, it was illegally stolen and republished in violation of United States & international trademark and copyright legislation. The correct version of this piece can be accessed at https://www.americanbankingnews.com/2017/05/27/dougherty-co-raises-athenahealth-inc-athn-price-target-to-148-00.html.

In related news, SVP Jonathan D. Porter sold 300 shares of the firm’s stock in a transaction that occurred on Monday, May 15th. The stock was sold at an average price of $109.48, for a total transaction of $32,844.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Bradford Kyle Armbrester sold 2,431 shares of the firm’s stock in a transaction that occurred on Thursday, May 18th. The shares were sold at an average price of $130.00, for a total value of $316,030.00. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 16,331 shares of company stock valued at $2,020,274. 3.04% of the stock is owned by corporate insiders.

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. BlackRock Fund Advisors raised its position in athenahealth by 2.3% in the third quarter. BlackRock Fund Advisors now owns 390,624 shares of the health services provider’s stock worth $49,265,000 after buying an additional 8,635 shares during the period. Northern Trust Corp raised its position in athenahealth by 2.9% in the third quarter. Northern Trust Corp now owns 456,464 shares of the health services provider’s stock worth $57,568,000 after buying an additional 12,669 shares during the period. Avalon Global Asset Management LLC raised its position in athenahealth by 9.5% in the third quarter. Avalon Global Asset Management LLC now owns 57,500 shares of the health services provider’s stock worth $7,252,000 after buying an additional 5,000 shares during the period. Bell State Bank & Trust raised its position in athenahealth by 5.7% in the third quarter. Bell State Bank & Trust now owns 2,615 shares of the health services provider’s stock worth $330,000 after buying an additional 142 shares during the period. Finally, Russell Investments Group Ltd. bought a new position in athenahealth during the fourth quarter worth $118,000.

About athenahealth

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

12 Month Chart for NASDAQ:ATHN

Receive News & Ratings for athenahealth Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc and related companies with MarketBeat.com's FREE daily email newsletter.